Shifting official development assistance during Covid-19
Earmarking, donor concentration and loans
Bibliographic Data
| ID | 21878687 |
|---|---|
| Authors | Liana Woskie (0000-0002-7451-6849, Tufts University), Clare Wenham (0000-0001-5378-3203, London School of Economics and Political Science, corresponding author) |
| Year | 2024 |
| Volume | 9 |
| Issue | 11 |
| Pages | e015527 |
| Publication date | 2024-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMJ Global Health (JOURNAL) |
| Journal identifiers | ISSN: 2059-7908 • E-ISSN: 2059-7908 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/bmjgh-2024-015527 |
| PMID | 39500617 |
| OpenAlex | W4404065754 |
| Language | EN |
| Citations received | 1 |
| References cited | 33 |
CONTEXT: In contrast to bilateral aid, aid disbursed from multilateral institutions increased significantly at the onset of the COVID-19 pandemic. Yet, at a time when a coherent and effective multilateral response is needed most, the COVID-19 pandemic revealed a shifting landscape of donor agencies that struggle with basic functions, such as cross-national coordination. While multilaterals are uniquely positioned to transcend national priorities and respond to pandemics, functionally we find official development assistance (ODA) from these entities may increasingly mimic the attributes of bilateral aid. We explore three important, but not comprehensive, attributes of aid leading up to and during the COVID-19 pandemic: (1) earmarking, (2) donor concentration and (3) aid modality. METHODS: We examine ODA disbursements over time in 2020 constant prices from 2010 to 2021 and plot share of inflow that is earmarked against each United Nations multilateral against their average annual financing volume. We then assess market diversity with two measures: the Shannon-Weiner Function and Gini-Simpson Index. Finally, we examine financing vehicles used to disburse and look at 'grant share' of total ODA from all formal donors over time. FINDINGS: We find that while the absolute number of formal multilateral actors and market diversity have been increasing since 2011, there has been a concurrent market consolidation led by the World Bank Group at 37% of market share in 2021. This coincides with an increasing prevalence of earmarking of aid inflows to the multilateral system and, unique to multilaterals but concerning given increasing debt risk, a rise in loan-based ODA disbursements. CONCLUSIONS: In theory, this consolidation may streamline revenue pooling and allow for a more collective approach to mitigating pandemic risk but, paired with increased earmarking, has the potential to sideline both collective goals (eg, the Sustainable Development Goals) and counties' core mandates (such as the pursuit of universal health coverage)
Business · Economics · Geography · Loan · Pandemic · Economic Growth and Development · Human Rights and Development · International Development and Aid · Medicine · Finance
The World Health Organization
Delegation under anarchy
The choice for multilateralism
Aid, Policies, and Growth
Who Gives Foreign Aid to Whom and Why?
Health and human rights are inextricably linked in the Covid-19 response
The Uncounted
Decolonising global health
Defining the global health system and systematically mapping its network of actors
China’s role as a global health donor in Africa
How to do (or not to do) … Tracking data on development assistance for health
Tracking development assistance for mental health
Inequality in Chile’s Philanthropic Ecosystem
Aid, Growth, and Devolution
The evolution, etiology and eventualities of the global health security regime
How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan
The Changing Role of the WORLD Bank in Global Health
Reimagining Global Health Governance in the Age of Covid-19
Why the Covid-19 response needs International Relations
Where Does the Money Go? Best and Worst Practices in Foreign Aid
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 1 |